Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael F Duarte

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2020
Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction SyndromeSherwin S Chan, Antonio Colecchia, Rafael F Duarte, et al.
Leukemia Research|April 20, 2011
Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemiaRafael F Duarte, Monserrat Arnan, Isabel Sánchez-Ortega, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2011
Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host diseaseIsabel Sánchez-Ortega, Octavio Servitje, Montserrat Arnan, et al.
Ejhaem|July 18, 2022
Secondary effects after belantamab treatment: A new anti-B-cell maturation antigen monoclonal antibody for multiple myelomaSara Garrido Paniagua, Pablo Prieto Martínez, Rafael Forés Cachón, et al.
American Journal of Hematology|August 29, 2025
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)Michelle L Schoettler, Sunil Kumar Pusarla, Narinder Nangia, et al.
Croatian Medical Journal|July 5, 2016
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseIsabel Sánchez-Ortega, Rocío Parody, Octavio Servitje, et al.
Journal of Medical Economics|April 2, 2013
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantationIsabel Sánchez-Ortega, Beatriz Patiño, Carmen Muñoz, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipientsIsabel Sánchez-Ortega, Lourdes Vázquez, Carmen Montes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2014
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxisRafael F Duarte, Isabel Sánchez-Ortega, Isabel Cuesta, et al.
Journal of Leukocyte Biology|January 20, 2024
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2-infected individuals interact with Fc receptor-expressing cells but do not neutralize the virusDaniel Fernández-Soto, Paula Bueno, Urtzi Garaigorta, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2020
Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction SyndromeSherwin S Chan, Antonio Colecchia, Rafael F Duarte, et al.
Leukemia Research|April 20, 2011
Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemiaRafael F Duarte, Monserrat Arnan, Isabel Sánchez-Ortega, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2011
Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host diseaseIsabel Sánchez-Ortega, Octavio Servitje, Montserrat Arnan, et al.
Ejhaem|July 18, 2022
Secondary effects after belantamab treatment: A new anti-B-cell maturation antigen monoclonal antibody for multiple myelomaSara Garrido Paniagua, Pablo Prieto Martínez, Rafael Forés Cachón, et al.
American Journal of Hematology|August 29, 2025
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)Michelle L Schoettler, Sunil Kumar Pusarla, Narinder Nangia, et al.
Croatian Medical Journal|July 5, 2016
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseIsabel Sánchez-Ortega, Rocío Parody, Octavio Servitje, et al.
Journal of Medical Economics|April 2, 2013
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantationIsabel Sánchez-Ortega, Beatriz Patiño, Carmen Muñoz, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipientsIsabel Sánchez-Ortega, Lourdes Vázquez, Carmen Montes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2014
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxisRafael F Duarte, Isabel Sánchez-Ortega, Isabel Cuesta, et al.
Journal of Leukocyte Biology|January 20, 2024
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2-infected individuals interact with Fc receptor-expressing cells but do not neutralize the virusDaniel Fernández-Soto, Paula Bueno, Urtzi Garaigorta, et al.
Pageof 12